Generalized exanthema due to hydroxychloroquine during COVID‐19 prophylaxis

Abstract

is a drug that is used for both chemoprophylaxis and treatment of COVID-19. At the moment, HCQ maintains its popularity and tens of thousands of people across the world are still receiving the current drug. 1 After the COVID-19 pandemic, several cutaneous side effects of HCQ are reported. 2-7 Herein, we reported generalized exanthema after a single dose of using HCQ. A 58-year-old male patient presented with resistant rashes on his upper extremities and neck region. Rashes appeared all over the body along with severe pruritus just a day after receiving a single 200 mg dose of oral hydroxychloroquine for COVID-19 prophylaxis. The patient had started hydroxychloroquine without any recommendation. He was also receiving pramipexole for restless legs syndrome for 3 years. He presented to our dermatology outpatient